Compare NVS & CRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVS | CRWD |
|---|---|---|
| Founded | 1895 | 2011 |
| Country | Switzerland | United States |
| Employees | 75267 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.5B | 165.5B |
| IPO Year | N/A | 2019 |
| Metric | NVS | CRWD |
|---|---|---|
| Price | $148.64 | $675.88 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 48 |
| Target Price | $144.00 | ★ $507.00 |
| AVG Volume (30 Days) | 1.3M | ★ 3.5M |
| Earning Date | 04-28-2026 | 06-02-2026 |
| Dividend Yield | ★ 2.16% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $4,812,005,000.00 |
| Revenue This Year | $2.30 | $24.85 |
| Revenue Next Year | $5.27 | $21.40 |
| P/E Ratio | ★ $23.13 | $6,543.36 |
| Revenue Growth | N/A | ★ 21.71 |
| 52 Week Low | $112.34 | $342.72 |
| 52 Week High | $170.46 | $785.66 |
| Indicator | NVS | CRWD |
|---|---|---|
| Relative Strength Index (RSI) | 49.64 | 59.78 |
| Support Level | $145.30 | $477.12 |
| Resistance Level | $152.55 | N/A |
| Average True Range (ATR) | 1.93 | 33.86 |
| MACD | -0.25 | 0.09 |
| Stochastic Oscillator | 59.99 | 46.13 |
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
CrowdStrike is a cloud-native cybersecurity company specializing in security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform, which provides enterprises with a unified view to detect and respond to security threats across their IT infrastructure. The Austin, Texas-based firm was founded in 2011 and went public in 2019.